United States · FDA National Drug Code directory
Alendronate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60723-205_460d461d-4807-2ed0-e063-6394a90aad4a
- Product NDC
- 60723-205
- Form
- TABLET
- Composition / generic term
- ALENDRONATE SODIUM
- Labeler
- Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171205
- Source listing expiry
- 20261231
Source-listed ingredients
- ALENDRONATE SODIUM — 70 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (60723-205-31) / 4 TABLET in 1 BLISTER PACK · 60723-205-31
- 3 BLISTER PACK in 1 CARTON (60723-205-32) / 4 TABLET in 1 BLISTER PACK · 60723-205-32
- 2 BLISTER PACK in 1 CARTON (60723-205-33) / 10 TABLET in 1 BLISTER PACK · 60723-205-33
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →